Site Search | NIAMS

Displaying 861 - 880 of 1043 results

Dr. Sarfaraz Hasni Receives 2021 Coleman Research Innovation Award

https://www.niams.nih.gov/es/node/10986

We are delighted to announce that Sarfaraz Hasni, M.D., Director of the NIAMS Lupus Clinical Trials Unit, has received the 2021 William G. Coleman Jr., Ph.D., Minority Health and Health Disparities Research Innovation Award.

Study finds link between red hair and pain threshold

https://www.niams.nih.gov/es/node/10991

Pankaj Sharma, Ph.D.

https://www.niams.nih.gov/es/node/10996

Dr. Sharma is a postdoctoral fellow in the Pediatric Translational Research Branch at the NIAMS. His research focuses on identifying genetic variations and determining molecular mechanisms associated with human diseases.

Developing medical countermeasures to protect civilians against intentional and accidental toxic chemical exposure that can lead to mass casualties is a major goal of the biodefense program at NIH. More specifically, this goal is executed by the Chemical Countermeasures Research Program (CCRP) administered by NIAID and executed in partnership with several other ICs across the NIH, including NIAMS.

FY 2022 Congressional Justification

https://www.niams.nih.gov/es/node/11091

Weight loss and exercise to improve rheumatoid arthritis cardiovascular risk

https://www.niams.nih.gov/es/node/11141

Clinical Trials in the Spotlight Main Page The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) supports a range of clinical trials studying new and existing interventions for prevention and treatment of arthritis, musculoskeletal, and skin diseases. Investigators supported by the NIAMS need your help finding individuals to

Living With Scoliosis

https://www.niams.nih.gov/es/node/11146

An NIH Health Capsule article. Scoliosis is a disease that causes the spine to curve. It can result in an abnormal s-shaped or c-shaped curve. Anyone can get scoliosis. But it’s most common in children age 11 and older.

Division of Extramural Research

https://www.niams.nih.gov/es/node/11181

The Division of Extramural Research (DER) provides scientific management of the largest federal investment on arthritis, musculoskeletal, and skin diseases research conducted in academic institutions across the country. The DER consists of several distinct scientific and special programs, each headed by a program director. DER works with leadership at NIAMS

Drs. Heidi Kong and Ian Myles — Derm Germs: The Human Skin Microbiome

https://www.niams.nih.gov/es/node/10146

Dr. Heidi Kong uses genomics to uncover the microbe-host interactions taking place all over our skin.

Scientists Use Clues in the Human Genome to Discover New Inflammatory Syndrome

https://www.niams.nih.gov/es/node/10216

Frequently Asked Questions for PAR-24-289 (R01) and PAR-25-230 (R21): Ancillary Studies to Ongoing Clinical Projects (Clinical Trial Not Allowed)

https://www.niams.nih.gov/es/node/10221

Applicants with additional questions are highly encouraged to contact their Program Director . These FAQs apply to the following funding opportunities: Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) (PAR-24-289) Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) (PAR-25-230)

Researchers Uncover Clues to Why Some Wounds Don’t Heal

https://www.niams.nih.gov/es/node/10281

Researchers identify defects in the wound healing process that might explain why diabetic foot ulcers heal slower or not at all.

NIH Researchers Discover a New Inflammatory Disease Called VEXAS

https://www.niams.nih.gov/es/node/10301

NIH scientists led an international team of researchers toward discovery of a new, adult-onset inflammatory disease abbreviated the VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome.

The Stephen I. Katz Early Stage Investigator Research Grant Program

https://www.niams.nih.gov/es/node/10306

Dr. Stephen I. Katz directed the National Institute of Arthritis and Musculoskeletal and Skin Diseases from August 1995 until his death in December 2018. He is remembered as an outstanding scientist, administrator, and civil servant who was committed to excellence, transparency, integrity, and public trust. But perhaps most noteworthy were

Elif Eren, Ph.D.

https://www.niams.nih.gov/es/node/10311

Dr. Eren is a structural biochemist studying viral protein interactions with host proteins, nucleic acids, and antibodies using x-ray crystallography and cryo-EM. Her research focuses on novel drug targets and therapeutics for HIV-1, HBV, and SARS-CoV-2.

New NIH Research Grants Honor Legacy of Former NIAMS Director Stephen I. Katz, M.D., Ph.D.

https://www.niams.nih.gov/es/node/10326

We at NIAMS are excited as we look forward to the arrival of Lindsey Criswell as the new Director but our thoughts also turn back to memories of our previous Director, Steve Katz. He was a unique voice who guided the NIAMS as director for more than two decades and who spent his career mentoring the next generations of researchers. With this in mind, I am pleased to share news of new awards that give the NIH a unique way to encourage the scientists of tomorrow.